A Case of Bone Marrow Carcinosis from Gastric Cancer That Presented Hypocalcemia Caused by Zoledronic Acid during the Treatment of Methotrexate/5-Fluorouracil Sequential Therapy

Author： Tsukasa Koichiro   Fujimoto Chinatsu   Ariyama Hiroshi   Esaki Taito   Murakawa Masahiro   Syoji Tetsuya   Baba Eishi   Hiranuma Seiichi  

Publisher： Sunmedia

ISSN： 0385-0684

Source： Japanese Journal of Cancer and Chemotherapy, Vol.36, Iss.3, 2009-03, pp. : 489-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: Efficacy of therapy and value of serum tumor markers

By Schulze-Bergkamen Henning   Zuna Ivan   Teufel Andreas   Stremmel Wolfgang   Rudi Jochen  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 43-53

Humana Press, Inc

Access to resources Recommend Favorite

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

By Gubanski Michael   Johnsson Anders   Fernebro Eva   Kadar Lianna   Karlberg Ingegerd   Flygare Petra   Berglund Åke   Glimelius Bengt   Lind Pehr  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 155-161

Springer Publishing Company

Access to resources Recommend Favorite

C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

By Sjostrom J.   Collan J.   von Boguslawski K.   Franssila K.   Bengtsson N.-O.   Mjaaland I.   Malmstrom P.   Ostenstad B.   Wist E.   Valvere V.   Bergh J.   Skiold-Petterson D.   Saksela E.   Blomqvist C.  

European Journal of Cancer, Vol. 38, Iss. 4, 2002-03 ,pp. : 535-542

Elsevier

Access to resources Recommend Favorite

Possible anti-tumor activity of initial treatment with zoledronic acid with hormonal therapy for bone-metastatic prostate cancer in multicenter clinical trial

By Uemura Hiroji  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 472-477

Springer Publishing Company

Access to resources Recommend Favorite